- Home
- IBOC vs PCVX Comparison
IBOC vs PCVX Comparison
Compare IBOC & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IBOC | PCVX |
|---|---|---|
| Founded | 1966 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 6.0B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | IBOC | PCVX |
|---|---|---|
| Price | $69.42 | $46.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $101.67 |
| AVG Volume (30 Days) | 228.9K | ★ 1.5M |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | ★ 2.02% | N/A |
| EPS Growth | ★ 5.13 | N/A |
| EPS | ★ 6.76 | N/A |
| Revenue | ★ $821,716,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.25 | ★ N/A |
| Revenue Growth | ★ 2.80 | N/A |
| 52 Week Low | $54.11 | $27.66 |
| 52 Week High | $73.58 | $94.60 |
Technical Indicators
Market Signals| Indicator | IBOC | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 61.30 | 51.97 |
| Support Level | $65.96 | $43.78 |
| Resistance Level | $67.70 | $48.11 |
| Average True Range (ATR) | 1.56 | 1.99 |
| MACD | 0.49 | -0.49 |
| Stochastic Oscillator | 91.05 | 42.99 |
Price Performance
Historical ComparisonAbout IBOC International Bancshares Corporation
International Bancshares Corp is a multibank financial holding company. The company provides commercial and retail banking services in Texas and Oklahoma. The services provided by the bank include checking, savings, bank cards, lending, insurance, mortgage, investments, and other services.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.